| CC | calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card... |
|---|---|
| CDPS | calcium-dependent protease small subunit |
| CDR | calcium-dependent regulator; clinical dementia rating; complementary determining region; computerize... |
| CEB | calcium entry blocker |
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
| ionised calcium | <biochemistry> The ionised calcium represents the calcium (Ca++) that is the metabolically active calcium. Normal values for ionised calcium in the bloodstream should be 4.4 to 5.3 mg/dl for adults and 4.4 to 6.0 mg/dl for children. Elevations may be seen in hyperparathyroidism, metastatic bone tumour, milk-alkali syndrome, multiple myeloma, Paget's disease, sarcoidosis, PTH-secreting tumours (paraneoplastic syndrome) and vitamin D intoxication. Lower than normal values may be seen in hypoparathyroidism, malabsorption, osteomalacia, pancreatitis, renal failure, rickets and vitamin D deficiency. (27 Sep 1997) |
|---|---|
| tertiary calcium phosphate | Ca3(PO4)2;used as an antacid. Synonym: bone ash, bone phosphate, tertiary calcium phosphate, tricalcium phosphate, whitlockite. (05 Mar 2000) |
| theophylline calcium salicylate | A mixture of calcium theophylline and sodium salicylate in molecular proportion; has the same actions and uses as theophylline. (05 Mar 2000) |
| edetate calcium disodium | Contracted name for a salt of ethylenediaminetetraacetate, an agent used as a chelator of lead and some other heavy metals. Available in several forms: disodium, sodium, and trisodium. (05 Mar 2000) |
| tribasic calcium phosphate | Ca3(PO4)2;used as an antacid. Synonym: bone ash, bone phosphate, tertiary calcium phosphate, tricalcium phosphate, whitlockite. (05 Mar 2000) |
| fenoprofen calcium | Calcium (±)-m-phenoxyhydratropate dihydrate;an anti-inflammatory analgesic used for treatment of mild to moderate pain and for osteoarthritis. (05 Mar 2000) |
| formol-calcium fixative | A fixative for preservation of lipids. (05 Mar 2000) |
| free calcium level | <biochemistry> The ionised calcium represents the calcium (Ca++) that is the metabolically active calcium. Normal values for ionised calcium in the bloodstream should be 4.4 to 5.3 mg/dl for adults and 4.4 to 6.0 mg/dl for children. Elevations may be seen in hyperparathyroidism, metastatic bone tumour, milk-alkali syndrome, multiple myeloma, Paget's disease, sarcoidosis, PTH-secreting tumours (paraneoplastic syndrome) and vitamin D intoxication. Lower than normal values may be seen in hypoparathyroidism, malabsorption, osteomalacia, pancreatitis, renal failure, rickets and vitamin D deficiency. (27 Sep 1997) |
| leucovorin calcium | <drug> The calcium salt of leucovorin (folinic acid); used to counteract toxic effects of folic acid antagonists, for the treatment of megaloblastic anaemias, and as an adjunct to cyanocobalamin in pernicious anaemia. Synonym: calcium folinate. (05 Mar 2000) |
| abortifacient agents | Chemical substances that interrupt pregnancy after implantation. (12 Dec 1998) |
| abortifacient agents, non-steroidal | Non-steroidal chemical compounds with abortifacient activity. (12 Dec 1998) |
| abortifacient agents, steroidal | Steroidal compounds with abortifacient activity. (12 Dec 1998) |
| adrenergic agents | Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (12 Dec 1998) |
| alkylating agents | Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agent, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (12 Dec 1998) |
| anti-allergic agents | Agents that are used to treat allergic reactions. most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (12 Dec 1998) |